IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sarissa Capital Management LP

Q1 2014 Holdings

Filed 2014-05-15 | 15 holdings | $290.4K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Ariad Pharmaceuticals IncCOM04033A100$96.7K12,000,00033.3%
Quest Diagnostics Inc(DGX)COM74834L100$44.9K775,00015.5%
Bio-Reference Labs IncCOM $.01 NEW09057G602$35.5K1,280,98412.2%
Idenix Pharmaceuticals IncCOM45166R204$30.5K5,050,10010.5%
Merck & Co Inc New(MRK)COM58933Y105$22.7K400,0007.8%
Mallinckrodt PUB LTD CoSHSG5785G107$17.4K274,8956.0%
Vivus IncCOM928551100$15.3K2,573,9435.3%
Repros Therapeutics IncCOM NEW76028H209$9.9K560,6003.4%
Aveo Pharmaceuticals(AVEOEUR)COM053588109$3.8K2,570,7591.3%
Laboratory Corp Amer HldgsCOM NEW50540R409$3.7K37,8241.3%
Intra Cellular Therapies Inc(ITCIEUR)COM46116X101$2.3K126,6950.8%
Onconova Therapeutics IncCOM68232V108$2.2K350,0000.8%
Enanta Pharmaceuticals Inc(ENTA)COM29251M106$2.0K50,0000.7%
Kindred Biosciences IncCOM494577109$1.9K101,8250.6%
Targacept IncCOM87611R306$1.6K329,5160.5%